Purpose. We have previously shown Glc-S-C7-Me (octyl beta-D-thioglucoside)
exhibits renal targeting potential in vivo in addition to its specific bind
ing to the renal membrane fraction in vitro. Thus, "alkylglycoside" is cons
idered to be a novel targeting vector for the kidney (1,2). The present stu
dy is designed to clarify the structural requirements for alkylglycoside as
a renal targeting vector.
Methods. Inhibitory effects of various sugars and glycosides on H-3-Glc-S-C
7-Me binding to the kidney membrane fraction were evaluated by a centrifuga
tion method.
Results. As far as the sugar moiety is concerned, no other sugars except D-
aldohexose and D-aldohexose derivatives (containing F, S, and N) showed gre
ater inhibition than D-glucose. Therefore, octylthio derivatives of various
D-aldohexose were prepared and their inhibitory effects were investigated.
The following findings were obtained: Equatorial OH at 4 position is essen
tial; OH at 2 position can have either orientation or be deleted. As far as
the alkyl moiety is concerned, the length, branching and electrical enviro
nment in the region of the glycoside bond are important; aromatic structure
s can substitute for the alkyl portion; the preferred glycoside bonding ato
m is as follows: S > NH > O.
Conclusions. The structural requirements for the renal targeting vector hav
e been identified to be as follows: a hydrophobic group (alkyl chain or aro
matic ring) should be introduced to a sugar (D-glucose, D-mannose, or 2-deo
xy-D-glucose) via a beta-glycoside binding atom (S > NH > O).